Biography

Dr. Hamilton-Williams holds a Career Development Fellowship from the Juvenile Diabetes Research Foundation. Her career has focused on understanding how immune tolerance is disrupted leading to the development of type 1 diabetes. Her early work was instrumental to our understanding of how defects in the interleukin-2 pathway are linked to type 1 diabetes. Currently a Senior Research Fellow at the University of Queensland Diamantina Institute, her laboratory now focuses on the role of the gut microbiota in type 1 diabetes as well as immunotherapeutic approaches aimed at restoring immune tolerance in type 1 diabetes. Recently, she demonstrated a role for genetic control of immune development in shaping the gut environment and the microbiota in type 1 diabetes. Her current research uses state-of-the-art proteomic techniques to probe how disturbances in the gut microbiota in children with type 1 diabetes and at-risk family members impact host intestinal and pancreatic function. She is currently involved in a clinical trial of a microbiome-targeting dietary supplement aimed at restoring a healthy microbiome and immune tolerance with an ultimate aim of preventing type 1 diabetes.

Video

Featured